Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem

Jarred M Griffin1, Frank Bradke1

  • 1Laboratory for Axonal Growth and Regeneration, German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.

EMBO Molecular Medicine
|February 25, 2020
PubMed

Insights

Combining therapies shows greater promise for spinal cord injury (SCI) recovery than single treatments alone. Future clinical trials must integrate these combined approaches for better patient outcomes.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Clinical Trials

Background:

  • Spinal cord injury (SCI) presents devastating neurological effects.
  • Emerging preclinical strategies for SCI are advancing towards clinical trials.
  • Individual SCI treatments yield modest recovery in animal models, limiting human therapeutic potential.

Purpose of the Study:

  • To highlight the limitations of individual SCI treatments.
  • To emphasize the superior outcomes of combinational strategies for SCI.
  • To advocate for the integration of combined therapies in future clinical trial designs.

Main Methods:

  • Review of preclinical strategies for spinal cord injury.
  • Analysis of outcomes from individual versus combinational therapeutic approaches.
  • Discussion of clinical trial design considerations for SCI.

Main Results:

  • Individual SCI treatments demonstrate limited efficacy.
  • Combinational strategies address multiple facets of SCI pathology, yielding enhanced recovery.
  • Future clinical trials need to incorporate combined therapeutic approaches.

Conclusions:

  • Combinational therapies offer a more effective strategy for spinal cord injury (SCI) treatment compared to single interventions.
  • Alignment of future clinical trial designs with combinational strategies is crucial for improving outcomes in human SCI patients.
  • Enhanced collaboration between basic researchers and clinicians is essential for optimizing SCI study designs and functional assessments.